Clinical trials: Infection, Soft Tissue
Human Herpesvirus 8
Suppression of Oral HHV8 Shedding With Valganciclovir
The purpose of the study is to use valganciclovir to define the role of antiviral therapy in suppression of HHV-8 shedding in HHV-8 seropositive men.
- Trial name
- NCT00194467
- Testing
- valganciclovir
- Where
- United States
- Volunteers
- 32 people
- Sponsor
- University of Washington
Gram-Positive Bacterial Infections, Soft Tissue Infections
Dalbavancin Outpatient Pilot
The purpose of this research is to determine if a new antibiotic called dalbavancin will work to treat and cure certain infections while reducing the need for daily antibiotics by vein.
- Trial name
- NCT03982030
- Testing
- Dalbavancin
- Sponsor
- Wake Forest University Health Sciences
Kaposi's Sarcoma
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
RATIONALE: PTC299 may stop the growth of Kaposi sarcoma by blocking blood flow to the tumor. PURPOSE: This phase I/II trial is studying the side effects and best dose of PTC299 and to see how well it works in treating patients…
- Trial name
- NCT00686842
- Testing
- VEGF inhibitor PTC299, gene expression analysis, polymerase chain reaction
- Where
- 8 sites in United States
- Volunteers
- 17 people
- Sponsor
- AIDS Malignancy Consortium
Osteosarcoma, Neuroblastoma
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
The purpose of this study is to find the largest safe dose of GD2-T cells (also called iC9-GD2-CAR-VZV-CTLs) in combination with a varicella zoster vaccine and lymohodepleting chemotherapy.
- Trial name
- VEGAS (NCT01953900)
- Testing
- GD2 T cells, VZV vaccine, Fludarabine
- Where
- 2 sites in United States
- Volunteers
- 26 people
- Sponsor
- Baylor College of Medicine
Kaposi Sarcoma, HIV Infections
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
To determine the safety of escalating IV doses of Tc 99m tilmanocept in HIV (human immunodeficiency virus) subjects with confirmed KS and to compare results obtained from subcutaneous and IV administrations of Tc 99m tilmanocept…
- Trial name
- NCT03157167
- Testing
- Tc99m-tilmanocept
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Navidea Biopharmaceuticals
Infectious Disease
The All Ireland Infectious Diseases Cohort Project
The All-Ireland Infectious Diseases (AIID) Cohort is a multicentre, prospective, longitudinal observational cohort that enrols consecutive adult subjects attending participating institutions for infectious disease services.
- Trial name
- AIID (NCT06410053)
- Where
- 9 sites in Ireland
- Volunteers
- 10,000 people
- Sponsor
- University College Dublin
Sarcoma, Kaposi, HIV Infections
A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
To evaluate the safety and effectiveness of Stealth liposomal doxorubicin hydrochloride (DOX-SL) in the long-term treatment of AIDS-related Kaposi's sarcoma (KS) in patients who previously had good responses to DOX-SL in…
- Trial name
- NCT00002319
- Testing
- Doxorubicin hydrochloride (liposomal)
- Where
- 33 sites in United States
- Sponsor
- Sequus Pharmaceuticals
Surgical Procedure, Unspecified, Soft Tissue Infections
Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes
The objective of this study is to compare two surgical techniques for the treatment of the mandibular bone atrophies: Dense PTFE titanium-reinforced membranes (Group A) versus Titanium mesh covered with cross-linked collagen…
- Conditions
- Surgical Procedure, Unspecified, Soft Tissue Infections, Bone Density, Bone Loss
- Trial name
- NCT04332679
- Testing
- Group A - control group, Group B - Test group
- Where
- Italy
- Volunteers
- 40 people
- Sponsor
- GBR Academy
Necrosis
NECROtizing Soft Tissue Infections and Their Scoring System
Primary Objective: The primary objective of this study is to develop and validate a clinical risk index score for identifying NSTIs in emergency general surgery patients being evaluated for a severe skin and soft tissue…
- Trial name
- NCT05224817
- Testing
- Necrotizing soft tissue infections (NSTIs)
- Where
- United States
- Volunteers
- 1,010 people
- Sponsor
- Methodist Health System
Sarcoma, Kaposi, HIV Infections
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
To evaluate the safety and toxicity of combination therapy for AIDS-associated Kaposi's sarcoma with zidovudine (AZT) and two kinds of interferon alpha.
- Trial name
- NCT00000725
- Testing
- Interferon alfa-2a, Zidovudine, Interferon alfa-n1
- Where
- United States
- Volunteers
- 56 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Skin and Soft Tissue Infections, Hiv
ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs
Access to Syringes at Pharmacies (ASAP) is a refinement of an evidence-based, pharmacy intervention to increase pharmacy-based sales of syringes to PWID in order to reduce bloodborne illnesses among them.
- Conditions
- Skin and Soft Tissue Infections, Hiv, Hepatitis C, Bloodstream Infection
- Trial name
- ASAP (NCT05270135)
- Testing
- ASAP
- Where
- United States
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- University of Arizona
Soft Tissue Infections
Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water
At present research has generated controversy regarding the utility of antiseptics in wound management for diabetic foot ulcers syndrome. However, these studies have been done in tissues and animal models.
- Trial name
- NCT02097615
- Testing
- chlorhexidine gluconate, deionized water
- Where
- Mexico
- Volunteers
- 24 people
- Sponsor
- Universidad de Guanajuato
Bacterial Infections
Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)
To collect the efficacy and safety information of Zithromax-SR related to their appropriate use in daily practice.
- Trial name
- NCT00998309
- Testing
- Azithromycin SR
- Volunteers
- 502 people
- Sponsor
- Pfizer
Sarcoma, Kaposi, HIV Infections
A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
To assess toxicity and determine the MTD of intravenous TNP-470 administered weekly in patients with AIDS-related Kaposi's sarcoma. To assess pharmacokinetics and tumor response of the drug.
- Trial name
- NCT00000763
- Testing
- TNP-470
- Where
- 6 sites in United States
- Volunteers
- 42 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Emergencies, Infusion Site Injury
Soft Tissue and Bone Diameter in Children and Adults for Intraosseus Access
Retrospective observational study: Soft tissue and bone diameters are assessed in MRI and CT scans of patients. Data is compared with recommendations of intraosseus needle producers to assess whether the information provided by…
- Conditions
- Emergencies, Infusion Site Injury, Bone Infection
- Trial name
- NCT03082066
- Testing
- CT or MRI scan
- Where
- Austria
- Volunteers
- 500 people
- Sponsor
- Medical University Innsbruck
Skin and Soft Tissue (SST) Infection
INSPIRE Trial for Skin and Soft Tissue Infections
The INSPIRE Skin and Soft Tissue Infection trial is a cluster-randomized controlled trial of HCA Healthcare hospitals comparing routine empiric antibiotic stewardship practices with real-time, precision medicine computerized…
- Trial name
- NCT05423756
- Testing
- Arm 1: Routine Care, Arm 2: INSPIRE Stewardship Bundle for Skin and Soft Tissue Infection
- Where
- 102 sites in United States
- Volunteers
- 118,562 people
- Sponsor
- Harvard Pilgrim Health Care
Soft Tissue Infections
Placebo Controlled Study of Antibiotic Treatment of Soft Tissue Infection
This study is to determine whether antibiotic therapy is needed for patients with non-life threatening soft tissue infections. Most patients with these soft tissue infections are presently treated with antibiotics.
- Trial name
- NCT00187759
- Testing
- cephalexin
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- University of California, San Francisco
Implant Site Infection
Vestibular Socket Therapy (VST) in Infected and Non Infected Sockets
Vestibular socket therapy with immediate implant placement is compared in infected and non-infected sockets regarding implant survival, bone thickness and soft tissue height .
- Trial name
- VST (NCT04787224)
- Testing
- immediate implant with vestibular socket therapy
- Where
- 2 sites in Egypt
- Volunteers
- 26 people
- Sponsor
- Cairo University
Sarcoma, Kaposi
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Background: The drug liposomal doxorubicin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Kaposi's sarcoma (KS).
- Trial name
- NCT00923936
- Testing
- Liposomal Doxorubicin, Bevacizumab
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- National Cancer Institute (NCI)
Community Acquired Pneumonia, Complicated Skin and Soft Tissue Infection
Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
MULTINATIONAL Retrospective Chart Review Study to Assess the Characteristics, Treatment Outcomes and Resource Use Among Adult Patients Hospitalized for Community-Acquired Pneumonia (CAP) or Complicated Skin and Soft Tissue…
- Trial name
- NCT04198571
- Testing
- Zinforo (ceftaroline fosamil)
- Where
- 26 sites in Brazil, Colombia and 5 more
- Volunteers
- 317 people
- Sponsor
- Pfizer